美国体外受精相关的医疗事故诉讼:法律文献综述
本文综述1993至2022年间美国涉及体外受精(IVF)的医疗事故诉讼,共纳入53例案件,分析原告指控与被告辩护的常见主题。
要点
- IVF医疗事故诉讼最常见为胚胎学实验室流程错误(45.3%)和遗传学检测错误(20.8%)。
- 54.7%案件判决支持IVF诊所或提供者,24.5%支持原告,20.8%仍在进行中。
核心结论
- IVF医疗事故索赔类型多样,最常见问题涉及胚胎学实验室流程和遗传学检测错误;提高警惕并实施严格的实验室和临床指南或可避免部分错误,了解特定司法辖区的立法和法院程序也可能帮助IVF提供者应对诉讼流程。
研究设计与样本
- 法律文献综述:检索Nexis Uni、Westlaw和CourtListener法律数据库,收集涉及IVF的医疗事故诉讼记录,从法院文件中提取案件性质、指控和结果。
- 共识别447例案件,其中53例同时涉及医疗事故和IVF,发生在1993年至2022年间。
主要发现
- 被告包括生殖内分泌科医生19例(35.8%)、学术机构17例(32.1%)、胚胎学人员9例(17.0%)、护理人员2例(3.8%)。
- 24例(45.3%)涉及胚胎学错误(如标本丢失和精子捐赠者错误),11例(20.8%)涉及植入前遗传学检测错误(如检测后仍出生遗传病患儿),6例(11.3%)涉及医学或手术并发症(如卵巢过度刺激综合征),4例(7.5%)涉及误诊(如周期开始前恶性肿瘤),3例(5.6%)涉及IVF结果虚假陈述,2例(3.8%)涉及医学资格筛查问题(如代孕者医学合并症),2例(3.8%)涉及保密泄露,1例(1.9%)涉及歧视。
- 最常见的次要索赔为过失(23例,占所有索赔的16.4%)、违约(13例,9.3%)、缺乏知情同意(11例,7.9%)和过失造成情感困扰(11例,7.9%)。
- 29例(54.7%)判决支持辩护的IVF诊所或提供者,13例(24.5%)判决支持原告,11例(20.8%)涉及正在进行的程序。
临床怎么用
- 作者认为,提高警惕并实施严格的实验室和临床指南或可避免部分错误。
- 作者认为,了解特定司法辖区的立法和法院程序可能有助于IVF提供者应对医疗事故诉讼流程。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Analysis of malpractice lawsuits that involve in vitro fertilization (IVF) can provide insight into the breadth of legal challenges faced by IVF clinics and the patient harms and financial consequences that can result from alleged errors in practice. OBJECTIVE: We aimed to review malpractice litigations involving IVF and identify common themes in plaintiff allegations and defense arguments. EVIDENCE REVIEW: We queried Nexis Uni, Westlaw, and CourtListener legal databases to collect records from malpractice litigations involving IVF. The nature of the cases, allegations, and outcomes were abstracted from court documents. FINDINGS: Of the 447 cases identified in the query, 53 involved both malpractice and IVF, occurring between 1993 and 2022. Defendants included a reproductive endocrinologist in 19 (35.8%) cases, an academic institution in 17 (32.1%) cases, embryology personnel in 9 (17.0%) cases, and nursing staff in 2 (3.8%) cases. Twenty-four (45.3%) cases involved embryology errors (e.g., lost specimens and incorrect sperm donor), 11 (20.8%) preimplantation genetic testing errors (e.g., child born with genetic illness despite testing), 6 (11.3%) medical or surgical complications (e.g., ovarian hyperstimulation syndrome), 4 (7.5%) misdiagnoses (e.g., malignancy before cycle start), 3 (5.6%) misrepresentations of IVF outcomes, 2 (3.8%) medical eligibility screening issues (e.g., medical comorbidities in a gestational carrier), 2 (3.8%) confidentiality breaches, and 1 (1.9%) case of discrimination. The most common secondary claims were negligence (23 cases, 16.4% of all claims), breach of contract (13, 9.3%), lack of informed consent (11, 7.9%), and negligent infliction of emotional distress (11, 7.9%). Twenty-nine (54.7%) cases were decided in favor of the defending IVF clinic or provider, 13 (24.5%) cases were decided in favor of the plaintiff, and 11 (20.8%) involved ongoing proceedings. Financial awards ranged from $4171 to $14,975,000, with the largest monetary award resulting from a cryostorage accident class action lawsuit. CONCLUSION: In vitro fertilization malpractice claims are varied, with the most common issues involving embryology laboratory processes and genetic testing errors. Some errors may be avoidable with increased vigilance and implementation of stringent laboratory and clinical guidelines. Understanding jurisdiction-specific legislation and court processes may also assist IVF providers in navigating the malpractice litigation process. RELEVANCE: This comprehensive review of IVF litigation may have the potential to promote practices that protect both providers and patients.
引用
- Applebaum J, Humphries LA, Nepps ME, et al. Malpractice litigation surrounding in vitro fertilization in the United States: a legal literature review. Fertil Steril. 2022. PMID: 36581015. doi:10.1016/j.fertnstert.2022.12.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。